EMA Authorised: Ecalta (anidulafungin) — Pfizer Europe MA EEIG

View source ↗

Summary

The European Medicines Agency authorised Ecalta (anidulafungin) for the treatment of candidiasis. Pfizer Europe MA EEIG is the marketing authorisation holder in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis

Drugs mentioned

• Ecalta (anidulafungin)

Snippet

Status: Authorised. Therapeutic area: Candidiasis. MAH: Pfizer Europe MA EEIG. Decision date: 09/09/2025